Ticker Symbol: RFL
Rafael Holdings Inc - Class B
$6.53 - 20-12-2024 4 p.m. ET
Exchange: NEW YORK STOCK EXCHANGE INC.
Currency:
USD
Asset
Type: Common Stock
CIK:0001713863
Company Profile
Rafael Holdings is focused on development of novel cancer therapies. The Company is a significant investor in two clinical stage oncology companies, Rafael Pharmaceuticals, Inc. and LipoMedix Pharmaceuticals Ltd. Through its wholly owned Barer Institute subsidiary, the Company is developing a pipeline of compounds focused on the regulation of cancer metabolism.
Sector: N/A
Industry: N/A
Standard Industrial Classification Code (SIC code): N/A
Address: N/A
Website: rafaelholdings.com
CEO: N/A
Tags:
- Technology Services
- Internet Software/Services
- Real Estate Development
- Finance
Pricing
Last Updated: October 13, 2023 03:00 PM EST
Previous Close: $1.86
Change:
-$0.04
(
-2.10%)
Days Range: $1.85 - $1.92
Beta: 0.61
52wk. High: $2.52
52wk. Low: $1.55
Ytd. Change -2.64%
50 Day Moving Average: $2.02
200 Day Moving Average: $2.06
Shares Outstanding: 23507565
Valuation
Market Cap: 4.4B
PE Ratio: -
EPS (TTM): 0
Dividends
Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A